ID   PKD2_DANRE              Reviewed;         904 AA.
AC   Q6IVV8; Q2VF27;
DT   10-MAY-2017, integrated into UniProtKB/Swiss-Prot.
DT   05-JUL-2004, sequence version 1.
DT   07-APR-2021, entry version 126.
DE   RecName: Full=Polycystin-2 {ECO:0000303|PubMed:16216239};
DE   AltName: Full=Curly up {ECO:0000303|PubMed:17360770};
DE            Short=Cup {ECO:0000303|PubMed:17360770};
DE   AltName: Full=Polycystic kidney disease 2 protein homolog;
DE   AltName: Full=Transient receptor potential cation channel subfamily P member 2;
GN   Name=pkd2 {ECO:0000312|ZFIN:ZDB-GENE-040827-4};
OS   Danio rerio (Zebrafish) (Brachydanio rerio).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Actinopterygii; Neopterygii; Teleostei; Ostariophysi; Cypriniformes;
OC   Danionidae; Danioninae; Danio.
OX   NCBI_TaxID=7955;
RN   [1] {ECO:0000312|EMBL:AAT39122.1}
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, AND DISRUPTION PHENOTYPE.
RX   PubMed=15269167; DOI=10.1242/dev.01240;
RA   Sun Z., Amsterdam A., Pazour G.J., Cole D.G., Miller M.S., Hopkins N.;
RT   "A genetic screen in zebrafish identifies cilia genes as a principal cause
RT   of cystic kidney.";
RL   Development 131:4085-4093(2004).
RN   [2] {ECO:0000312|EMBL:ABA60692.1}
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, DISRUPTION PHENOTYPE, AND
RP   DEVELOPMENTAL STAGE.
RX   PubMed=16216239; DOI=10.1016/j.ydbio.2005.08.047;
RA   Bisgrove B.W., Snarr B.S., Emrazian A., Yost H.J.;
RT   "Polaris and polycystin-2 in dorsal forerunner cells and Kupffer's vesicle
RT   are required for specification of the zebrafish left-right axis.";
RL   Dev. Biol. 287:274-288(2005).
RN   [3] {ECO:0000312|Ensembl:ENSDARP00000027024, ECO:0000312|Proteomes:UP000000437}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Tuebingen {ECO:0000312|Ensembl:ENSDARP00000027024,
RC   ECO:0000312|Proteomes:UP000000437};
RX   PubMed=23594743; DOI=10.1038/nature12111;
RA   Howe K., Clark M.D., Torroja C.F., Torrance J., Berthelot C., Muffato M.,
RA   Collins J.E., Humphray S., McLaren K., Matthews L., McLaren S., Sealy I.,
RA   Caccamo M., Churcher C., Scott C., Barrett J.C., Koch R., Rauch G.J.,
RA   White S., Chow W., Kilian B., Quintais L.T., Guerra-Assuncao J.A., Zhou Y.,
RA   Gu Y., Yen J., Vogel J.H., Eyre T., Redmond S., Banerjee R., Chi J., Fu B.,
RA   Langley E., Maguire S.F., Laird G.K., Lloyd D., Kenyon E., Donaldson S.,
RA   Sehra H., Almeida-King J., Loveland J., Trevanion S., Jones M., Quail M.,
RA   Willey D., Hunt A., Burton J., Sims S., McLay K., Plumb B., Davis J.,
RA   Clee C., Oliver K., Clark R., Riddle C., Elliot D., Threadgold G.,
RA   Harden G., Ware D., Begum S., Mortimore B., Kerry G., Heath P.,
RA   Phillimore B., Tracey A., Corby N., Dunn M., Johnson C., Wood J., Clark S.,
RA   Pelan S., Griffiths G., Smith M., Glithero R., Howden P., Barker N.,
RA   Lloyd C., Stevens C., Harley J., Holt K., Panagiotidis G., Lovell J.,
RA   Beasley H., Henderson C., Gordon D., Auger K., Wright D., Collins J.,
RA   Raisen C., Dyer L., Leung K., Robertson L., Ambridge K., Leongamornlert D.,
RA   McGuire S., Gilderthorp R., Griffiths C., Manthravadi D., Nichol S.,
RA   Barker G., Whitehead S., Kay M., Brown J., Murnane C., Gray E.,
RA   Humphries M., Sycamore N., Barker D., Saunders D., Wallis J., Babbage A.,
RA   Hammond S., Mashreghi-Mohammadi M., Barr L., Martin S., Wray P.,
RA   Ellington A., Matthews N., Ellwood M., Woodmansey R., Clark G., Cooper J.,
RA   Tromans A., Grafham D., Skuce C., Pandian R., Andrews R., Harrison E.,
RA   Kimberley A., Garnett J., Fosker N., Hall R., Garner P., Kelly D., Bird C.,
RA   Palmer S., Gehring I., Berger A., Dooley C.M., Ersan-Urun Z., Eser C.,
RA   Geiger H., Geisler M., Karotki L., Kirn A., Konantz J., Konantz M.,
RA   Oberlander M., Rudolph-Geiger S., Teucke M., Lanz C., Raddatz G.,
RA   Osoegawa K., Zhu B., Rapp A., Widaa S., Langford C., Yang F.,
RA   Schuster S.C., Carter N.P., Harrow J., Ning Z., Herrero J., Searle S.M.,
RA   Enright A., Geisler R., Plasterk R.H., Lee C., Westerfield M.,
RA   de Jong P.J., Zon L.I., Postlethwait J.H., Nusslein-Volhard C.,
RA   Hubbard T.J., Roest Crollius H., Rogers J., Stemple D.L.;
RT   "The zebrafish reference genome sequence and its relationship to the human
RT   genome.";
RL   Nature 496:498-503(2013).
RN   [4]
RP   DISRUPTION PHENOTYPE, FUNCTION, TISSUE SPECIFICITY, SUBCELLULAR LOCATION,
RP   AND DEVELOPMENTAL STAGE.
RX   PubMed=16943304; DOI=10.1681/asn.2006040412;
RA   Obara T., Mangos S., Liu Y., Zhao J., Wiessner S., Kramer-Zucker A.G.,
RA   Olale F., Schier A.F., Drummond I.A.;
RT   "Polycystin-2 immunolocalization and function in zebrafish.";
RL   J. Am. Soc. Nephrol. 17:2706-2718(2006).
RN   [5]
RP   DISRUPTION PHENOTYPE, AND PHOSPHORYLATION.
RX   PubMed=16551655; DOI=10.1093/hmg/ddl070;
RA   Streets A.J., Moon D.J., Kane M.E., Obara T., Ong A.C.;
RT   "Identification of an N-terminal glycogen synthase kinase 3 phosphorylation
RT   site which regulates the functional localization of polycystin-2 in vivo
RT   and in vitro.";
RL   Hum. Mol. Genet. 15:1465-1473(2006).
RN   [6]
RP   FUNCTION, DISRUPTION PHENOTYPE, DEVELOPMENTAL STAGE, AND MUTAGENESIS OF
RP   LEU-351.
RX   PubMed=17360770; DOI=10.1242/dev.02827;
RA   Schottenfeld J., Sullivan-Brown J., Burdine R.D.;
RT   "Zebrafish curly up encodes a Pkd2 ortholog that restricts left-side-
RT   specific expression of southpaw.";
RL   Development 134:1605-1615(2007).
RN   [7]
RP   DISRUPTION PHENOTYPE, FUNCTION, TISSUE SPECIFICITY, AND SUBCELLULAR
RP   LOCATION.
RX   PubMed=23376035; DOI=10.1016/j.yjmcc.2013.01.015;
RA   Paavola J., Schliffke S., Rossetti S., Kuo I.Y., Yuan S., Sun Z.,
RA   Harris P.C., Torres V.E., Ehrlich B.E.;
RT   "Polycystin-2 mutations lead to impaired calcium cycling in the heart and
RT   predispose to dilated cardiomyopathy.";
RL   J. Mol. Cell. Cardiol. 58:199-208(2013).
RN   [8]
RP   DISRUPTION PHENOTYPE, DEVELOPMENTAL STAGE, TISSUE SPECIFICITY, AND
RP   SUBCELLULAR LOCATION.
RX   PubMed=26432887; DOI=10.1242/bio.014076;
RA   Roxo-Rosa M., Jacinto R., Sampaio P., Lopes S.S.;
RT   "The zebrafish Kupffer's vesicle as a model system for the molecular
RT   mechanisms by which the lack of Polycystin-2 leads to stimulation of
RT   CFTR.";
RL   Biol. Open 4:1356-1366(2015).
RN   [9]
RP   FUNCTION, AND DISRUPTION PHENOTYPE.
RX   PubMed=25660539; DOI=10.1016/j.cub.2014.12.051;
RA   Yuan S., Zhao L., Brueckner M., Sun Z.;
RT   "Intraciliary calcium oscillations initiate vertebrate left-right
RT   asymmetry.";
RL   Curr. Biol. 25:556-567(2015).
CC   -!- FUNCTION: Component of a heteromeric calcium-permeable ion channel
CC       formed by PKD1 and PKD2 that is activated by interaction between PKD1
CC       and a Wnt family member, such as WNT3A and WNT9B. Can also form a
CC       functional, homotetrameric ion channel (By similarity). Functions as
CC       non-selective, voltage-gated cation channel (By similarity). Required
CC       for normal oscillation of Ca(2+) levels within cilia; these
CC       oscillations of the intraciliary Ca(2+) levels can trigger cytoplasmic
CC       Ca(2+) signaling cascades (PubMed:25660539). May contribute to the
CC       release of Ca(2+) stores from the endoplasmic reticulum (By
CC       similarity). Required for normal temporal variation of the
CC       intracellular Ca(2+) levels in the heart (PubMed:23376035). Plays a
CC       role in fluid-flow mechanosensation (By similarity). Required for
CC       normal specification of the body left-right axis during embryogenesis,
CC       most likely via its role in ciliary Ca(2+) oscillations in Kupffer's
CC       vesicle (PubMed:15269167, PubMed:16216239, PubMed:16943304,
CC       PubMed:17360770, PubMed:23376035, PubMed:25660539).
CC       {ECO:0000250|UniProtKB:O35245, ECO:0000250|UniProtKB:Q13563,
CC       ECO:0000269|PubMed:15269167, ECO:0000269|PubMed:16216239,
CC       ECO:0000269|PubMed:16943304, ECO:0000269|PubMed:17360770,
CC       ECO:0000269|PubMed:23376035, ECO:0000269|PubMed:25660539}.
CC   -!- ACTIVITY REGULATION: Channel activity is regulated by phosphorylation.
CC       Channel activity is regulated by intracellular Ca(2+).
CC       {ECO:0000250|UniProtKB:Q13563}.
CC   -!- SUBUNIT: Homotetramer (By similarity). Heterotetramer with pkd1, giving
CC       rise to a complex formed by one pkd1 chain and three pkd2 chains (By
CC       similarity). Interacts with pkd1l1 (By similarity).
CC       {ECO:0000250|UniProtKB:H2LRU7, ECO:0000250|UniProtKB:Q13563}.
CC   -!- SUBCELLULAR LOCATION: Basolateral cell membrane
CC       {ECO:0000269|PubMed:16943304}; Multi-pass membrane protein
CC       {ECO:0000250|UniProtKB:Q13563}. Cell membrane, sarcolemma
CC       {ECO:0000269|PubMed:16943304}. Cytoplasm, myofibril, sarcomere
CC       {ECO:0000269|PubMed:16943304}. Sarcoplasmic reticulum membrane
CC       {ECO:0000269|PubMed:23376035}. Apical cell membrane
CC       {ECO:0000269|PubMed:16943304}; Multi-pass membrane protein
CC       {ECO:0000250|UniProtKB:Q13563}. Endoplasmic reticulum membrane
CC       {ECO:0000305|PubMed:26432887}; Multi-pass membrane protein
CC       {ECO:0000250|UniProtKB:Q13563}. Cell projection, cilium
CC       {ECO:0000269|PubMed:16943304, ECO:0000269|PubMed:26432887}. Cytoplasm,
CC       cytoskeleton, cilium basal body {ECO:0000269|PubMed:26432887}.
CC       Cytoplasmic vesicle membrane {ECO:0000269|PubMed:16943304}.
CC       Note=Detected at the basolateral cell membrane and on apical, lumenal
CC       cilia in anterior, proximal pronephric ducts, and in intracellular
CC       vesicles in the posterior part of the pronephric duct. Detected on
CC       apical cell membranes on epithelial cells in the ear.
CC       {ECO:0000269|PubMed:16943304}.
CC   -!- TISSUE SPECIFICITY: Detected along cilia and at the cilium basal body
CC       in Kupffer's vesicle at the 10 somite stage (PubMed:26432887). Detected
CC       in heart at 48hpf (PubMed:23376035). Detected in muscle and pronephric
CC       kidney at 48 hpf (PubMed:16943304). Detected on trunk muscle sarcolemma
CC       and sarcomere, on ependymal cell cilia in brain, at the apical cell
CC       membrane in epithelial cells in the ear, at the lateral line organ and
CC       olfactory placode at 56 hpf (PubMed:16943304). Detected in adult kidney
CC       (at protein level) (PubMed:16943304). {ECO:0000269|PubMed:16943304,
CC       ECO:0000269|PubMed:26432887}.
CC   -!- DEVELOPMENTAL STAGE: First detected at the onset of gastrulation in a
CC       band at the blastoderm margin (PubMed:16216239, PubMed:17360770).
CC       Ubiquitous during gastrulation, somatogenesis and at 48 hpf
CC       (PubMed:16943304). During gastrulation, detected at the hypoblast of
CC       the dorsal midline and in dorsal forerunner cells that form a ciliated
CC       Kupffer's vesicle later on (PubMed:16216239, PubMed:17360770,
CC       PubMed:26432887). Ubiquitous during early somite stages, with high
CC       levels of expression in Kupffer's vesicle (PubMed:16216239,
CC       PubMed:17360770). At subsequent stages, detected in pronephric duct
CC       primordia and neural floorplate (PubMed:16216239, PubMed:16943304,
CC       PubMed:17360770, PubMed:26432887). Highly expressed in brain at 24 hpf
CC       (PubMed:16216239). At 3 dpf, detected at pharyngeal arches and the
CC       pectoral fin bud (PubMed:16216239). {ECO:0000269|PubMed:16216239,
CC       ECO:0000269|PubMed:16943304, ECO:0000269|PubMed:17360770,
CC       ECO:0000269|PubMed:26432887}.
CC   -!- DOMAIN: The C-terminal coiled-coil domain is involved in
CC       oligomerization. The coiled-coil domain binds calcium and undergoes a
CC       calcium-induced conformation change (in vitro).
CC       {ECO:0000250|UniProtKB:Q13563}.
CC   -!- PTM: Phosphorylated. Phosphorylation is important for protein function;
CC       a mutant human construct that lacks the N-terminal phosphorylation
CC       sites cannot complement a zebrafish pkd2-deficient mutant.
CC       {ECO:0000269|PubMed:16551655}.
CC   -!- PTM: N-glycosylated. The four subunits in a tetramer probably differ in
CC       the extent of glycosylation; simultaneous glycosylation of all
CC       experimentally validated sites would probably create steric hindrance.
CC       {ECO:0000250|UniProtKB:Q13563}.
CC   -!- DISRUPTION PHENOTYPE: Morpholino knockdown of the protein impairs
CC       specification of the left-right axis during embryonic development and
CC       randomization of heart and gut looping, plus misexpression of left-side
CC       specific genes (PubMed:16216239, PubMed:16943304, PubMed:17360770,
CC       PubMed:26432887, PubMed:25660539). Morpholino knockdown of the protein
CC       causes body curvature, tail curling, hydrocephalus and kidney cysts
CC       (PubMed:15269167, PubMed:16216239, PubMed:16943304, PubMed:16551655,
CC       PubMed:17360770, PubMed:23376035, PubMed:26432887). Morpholino
CC       knockdown has no effect on number, length or motility of pronephric
CC       cilia, but the fluid flow through the pronephric ducts seems to be
CC       impaired due to physical obstruction of the ducts (PubMed:16943304).
CC       Likewise, morpholino knockdown of the protein has no effect on the
CC       motility of cilia in Kupffer's vesicle (PubMed:25660539). Morpholino
CC       knockdown of the protein leads to an increase of the volume of
CC       Kupffer's vesicle, without any change in the proliferation of the cells
CC       that line the vesicle (PubMed:26432887). Morpholino knockdown of the
CC       protein leads to impaired heart function, characterized by arrhytmia
CC       and frequently associated with pericardial and abdominal edema and
CC       atrioventricular block (PubMed:23376035). {ECO:0000269|PubMed:15269167,
CC       ECO:0000269|PubMed:16216239, ECO:0000269|PubMed:16551655,
CC       ECO:0000269|PubMed:16943304, ECO:0000269|PubMed:17360770,
CC       ECO:0000269|PubMed:23376035, ECO:0000269|PubMed:26432887}.
CC   -!- SIMILARITY: Belongs to the polycystin family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AY618926; AAT39122.1; -; mRNA.
DR   EMBL; DQ175629; ABA60692.1; -; mRNA.
DR   EMBL; CR788312; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   RefSeq; NP_001002310.1; NM_001002310.1.
DR   RefSeq; XP_009292468.1; XM_009294193.2.
DR   SMR; Q6IVV8; -.
DR   STRING; 7955.ENSDARP00000027024; -.
DR   PaxDb; Q6IVV8; -.
DR   Ensembl; ENSDART00000020412; ENSDARP00000027024; ENSDARG00000014098.
DR   GeneID; 432387; -.
DR   KEGG; dre:432387; -.
DR   CTD; 5311; -.
DR   ZFIN; ZDB-GENE-040827-4; pkd2.
DR   eggNOG; KOG3599; Eukaryota.
DR   GeneTree; ENSGT00940000159025; -.
DR   HOGENOM; CLU_012097_0_0_1; -.
DR   InParanoid; Q6IVV8; -.
DR   OMA; YHGAGHP; -.
DR   OrthoDB; 426073at2759; -.
DR   PhylomeDB; Q6IVV8; -.
DR   TreeFam; TF316484; -.
DR   Reactome; R-DRE-5620916; VxPx cargo-targeting to cilium.
DR   PRO; PR:Q6IVV8; -.
DR   Proteomes; UP000000437; Chromosome 1.
DR   Bgee; ENSDARG00000014098; Expressed in multi-cellular organism and 35 other tissues.
DR   GO; GO:0016324; C:apical plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0016323; C:basolateral plasma membrane; IDA:ZFIN.
DR   GO; GO:0034703; C:cation channel complex; ISS:UniProtKB.
DR   GO; GO:0005929; C:cilium; IDA:ZFIN.
DR   GO; GO:0030659; C:cytoplasmic vesicle membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005856; C:cytoskeleton; IEA:UniProtKB-KW.
DR   GO; GO:0005783; C:endoplasmic reticulum; IDA:ZFIN.
DR   GO; GO:0005887; C:integral component of plasma membrane; ISS:UniProtKB.
DR   GO; GO:0016328; C:lateral plasma membrane; ISS:ZFIN.
DR   GO; GO:0016020; C:membrane; IBA:GO_Central.
DR   GO; GO:0042383; C:sarcolemma; IEA:UniProtKB-SubCell.
DR   GO; GO:0030017; C:sarcomere; IEA:UniProtKB-SubCell.
DR   GO; GO:0033017; C:sarcoplasmic reticulum membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005262; F:calcium channel activity; ISS:UniProtKB.
DR   GO; GO:0005509; F:calcium ion binding; IBA:GO_Central.
DR   GO; GO:0005261; F:cation channel activity; ISS:UniProtKB.
DR   GO; GO:0051371; F:muscle alpha-actinin binding; IBA:GO_Central.
DR   GO; GO:0015271; F:outward rectifier potassium channel activity; ISS:UniProtKB.
DR   GO; GO:0005267; F:potassium channel activity; IBA:GO_Central.
DR   GO; GO:0005102; F:signaling receptor binding; IBA:GO_Central.
DR   GO; GO:0005245; F:voltage-gated calcium channel activity; IBA:GO_Central.
DR   GO; GO:0005248; F:voltage-gated sodium channel activity; IBA:GO_Central.
DR   GO; GO:0003171; P:atrioventricular valve development; IMP:ZFIN.
DR   GO; GO:0070588; P:calcium ion transmembrane transport; ISS:UniProtKB.
DR   GO; GO:0198738; P:cell-cell signaling by wnt; ISS:UniProtKB.
DR   GO; GO:0071277; P:cellular response to calcium ion; ISS:UniProtKB.
DR   GO; GO:0097704; P:cellular response to oscillatory fluid shear stress; IMP:ZFIN.
DR   GO; GO:0060271; P:cilium assembly; IMP:ZFIN.
DR   GO; GO:0050982; P:detection of mechanical stimulus; IBA:GO_Central.
DR   GO; GO:0061371; P:determination of heart left/right asymmetry; IMP:ZFIN.
DR   GO; GO:0007368; P:determination of left/right symmetry; IMP:ZFIN.
DR   GO; GO:0009953; P:dorsal/ventral pattern formation; IMP:ZFIN.
DR   GO; GO:0003143; P:embryonic heart tube morphogenesis; IMP:ZFIN.
DR   GO; GO:0007507; P:heart development; IMP:CACAO.
DR   GO; GO:0003146; P:heart jogging; IMP:ZFIN.
DR   GO; GO:0001947; P:heart looping; IMP:ZFIN.
DR   GO; GO:0002244; P:hematopoietic progenitor cell differentiation; IMP:ZFIN.
DR   GO; GO:0098662; P:inorganic cation transmembrane transport; ISS:UniProtKB.
DR   GO; GO:0001822; P:kidney development; IMP:ZFIN.
DR   GO; GO:0070121; P:Kupffer's vesicle development; IMP:ZFIN.
DR   GO; GO:0060972; P:left/right pattern formation; IMP:ZFIN.
DR   GO; GO:0001946; P:lymphangiogenesis; IMP:ZFIN.
DR   GO; GO:0007219; P:Notch signaling pathway; IMP:ZFIN.
DR   GO; GO:0051284; P:positive regulation of sequestering of calcium ion; IMP:CACAO.
DR   GO; GO:0071805; P:potassium ion transmembrane transport; ISS:UniProtKB.
DR   GO; GO:0048793; P:pronephros development; IMP:ZFIN.
DR   GO; GO:0072114; P:pronephros morphogenesis; IMP:ZFIN.
DR   GO; GO:0051290; P:protein heterotetramerization; ISS:UniProtKB.
DR   GO; GO:0051262; P:protein tetramerization; ISS:UniProtKB.
DR   GO; GO:0065003; P:protein-containing complex assembly; IPI:ZFIN.
DR   GO; GO:0072019; P:proximal convoluted tubule development; IMP:ZFIN.
DR   GO; GO:0010882; P:regulation of cardiac muscle contraction by calcium ion signaling; IMP:ZFIN.
DR   GO; GO:0032965; P:regulation of collagen biosynthetic process; IMP:ZFIN.
DR   GO; GO:0034765; P:regulation of ion transmembrane transport; IEA:UniProtKB-KW.
DR   GO; GO:0051209; P:release of sequestered calcium ion into cytosol; IBA:GO_Central.
DR   GO; GO:0003173; P:ventriculo bulbo valve development; IMP:ZFIN.
DR   GO; GO:0016055; P:Wnt signaling pathway; IEA:UniProtKB-KW.
DR   Gene3D; 1.20.120.350; -; 1.
DR   InterPro; IPR011992; EF-hand-dom_pair.
DR   InterPro; IPR002048; EF_hand_dom.
DR   InterPro; IPR013122; PKD1_2_channel.
DR   InterPro; IPR003915; PKD_2.
DR   InterPro; IPR027359; Volt_channel_dom_sf.
DR   Pfam; PF08016; PKD_channel; 1.
DR   PRINTS; PR01433; POLYCYSTIN2.
DR   SUPFAM; SSF47473; SSF47473; 1.
DR   PROSITE; PS50222; EF_HAND_2; 2.
PE   1: Evidence at protein level;
KW   Calcium; Calcium channel; Calcium transport; Cell membrane;
KW   Cell projection; Cilium; Coiled coil; Cytoplasm; Cytoplasmic vesicle;
KW   Cytoskeleton; Disulfide bond; Endoplasmic reticulum; Glycoprotein;
KW   Ion channel; Ion transport; Membrane; Metal-binding; Phosphoprotein;
KW   Potassium; Potassium channel; Potassium transport; Reference proteome;
KW   Sarcoplasmic reticulum; Transmembrane; Transmembrane helix; Transport;
KW   Voltage-gated channel; Wnt signaling pathway.
FT   CHAIN           1..904
FT                   /note="Polycystin-2"
FT                   /id="PRO_0000439854"
FT   TOPO_DOM        1..155
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250|UniProtKB:Q13563"
FT   TRANSMEM        156..177
FT                   /note="Helical; Name=S1"
FT                   /evidence="ECO:0000250|UniProtKB:Q13563"
FT   TOPO_DOM        178..404
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000250|UniProtKB:Q13563"
FT   TRANSMEM        405..425
FT                   /note="Helical; Name=S2"
FT                   /evidence="ECO:0000250|UniProtKB:Q13563"
FT   TOPO_DOM        426..441
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250|UniProtKB:Q13563"
FT   TRANSMEM        442..462
FT                   /note="Helical; Name=S3"
FT                   /evidence="ECO:0000250|UniProtKB:Q13563"
FT   TOPO_DOM        463..489
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000250|UniProtKB:Q13563"
FT   TRANSMEM        490..510
FT                   /note="Helical; Name=S4"
FT                   /evidence="ECO:0000250|UniProtKB:Q13563"
FT   TOPO_DOM        511..534
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250|UniProtKB:Q13563"
FT   TRANSMEM        535..556
FT                   /note="Helical; Name=5"
FT                   /evidence="ECO:0000250|UniProtKB:Q13563"
FT   TOPO_DOM        557..568
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000250|UniProtKB:Q13563"
FT   INTRAMEM        569..583
FT                   /note="Pore-forming"
FT                   /evidence="ECO:0000250|UniProtKB:Q13563"
FT   TOPO_DOM        584..591
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000250|UniProtKB:Q13563"
FT   TRANSMEM        592..612
FT                   /note="Helical; Name=S6"
FT                   /evidence="ECO:0000250|UniProtKB:Q13563"
FT   TOPO_DOM        613..904
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250|UniProtKB:Q13563"
FT   DOMAIN          687..722
FT                   /note="EF-hand"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00448"
FT   CA_BIND         700..711
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00448"
FT   REGION          740..759
FT                   /note="Linker"
FT                   /evidence="ECO:0000250|UniProtKB:Q13563"
FT   COILED          770..809
FT                   /evidence="ECO:0000250|UniProtKB:Q13563"
FT   MOTIF           578..580
FT                   /note="Selectivity filter"
FT                   /evidence="ECO:0000250|UniProtKB:Q13563"
FT   METAL           700
FT                   /note="Calcium"
FT                   /evidence="ECO:0000250|UniProtKB:Q13563"
FT   METAL           702
FT                   /note="Calcium"
FT                   /evidence="ECO:0000250|UniProtKB:Q13563"
FT   METAL           704
FT                   /note="Calcium"
FT                   /evidence="ECO:0000250|UniProtKB:Q13563"
FT   METAL           706
FT                   /note="Calcium; via carbonyl oxygen"
FT                   /evidence="ECO:0000250|UniProtKB:Q13563"
FT   METAL           711
FT                   /note="Calcium"
FT                   /evidence="ECO:0000250|UniProtKB:Q13563"
FT   CARBOHYD        235
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00498"
FT   CARBOHYD        241
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00498"
FT   CARBOHYD        264
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00498"
FT   CARBOHYD        298
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00498"
FT   CARBOHYD        478
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00498"
FT   DISULFID        267..280
FT                   /evidence="ECO:0000250|UniProtKB:Q13563"
FT   MUTAGEN         351
FT                   /note="L->P: In ty30b; curly tail phenotype and impaired
FT                   left-right patterning."
FT                   /evidence="ECO:0000269|PubMed:17360770"
FT   CONFLICT        15
FT                   /note="A -> V (in Ref. 2; ABA60692)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        130
FT                   /note="L -> P (in Ref. 2; ABA60692)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        325
FT                   /note="G -> R (in Ref. 2; ABA60692)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        334
FT                   /note="T -> A (in Ref. 2; ABA60692)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        604..608
FT                   /note="FIFMI -> LIFMV (in Ref. 2; ABA60692)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   904 AA;  103269 MW;  53B45F174BB50E5E CRC64;
     MSSSRVRPQA PQSPAASASA SPPPHEGIEM EKMHHEEVGL GVPDETPSSP PTSSSRQAWS
     RDNPGFEPEE GMMEADWPPE SQGRRSVSTT SSSSSGGVPG NFSGISARIN RGLYPTPPAQ
     EHRSCGKRIL EKMRVLWDTR LLGESNSNRE MYLKTVLREM ITYILFLLTL CIITYGMVST
     NMYYYTKVMS QLFLDTPLSS GEPTNFKSLS TMEDFWKFTE GPFLNGMYWE LWYNNKSLPE
     NQSLIYYENL LLGVPRLRQL RVRNESCSVH EDLRDEVYDC YNVYSPANED KAPFGPKNGT
     AWRFKDESSL GESSYWGQVS TYGGGGYYQD LSRTREKSAN QLQELKNNLW LDRGTRAVFL
     DFSIYNGNVN LFCIVRLLVE FPATGGAVPS WQFQTVRLLR YVSSWDYFVG MCEVSFCLFV
     LYYLVEEALE IRLHRLRYFK SLWNCLDVLI VALSVPAIIM NICRTSAVSH RLHFLLENHS
     TYPNFEPLAR LQVHFNNLAA IIVFLSWVKL FKFINFNKTM NQLSTTMSRC AKDLMGFAIM
     FFIVFLAYAQ LAYLVFGTQV NDFSTFQACI FTQFRIILGD FDFSEIEEAD SVLGPIYFTT
     FVFFIFMILL NMFLAIINDT YSEVKADMAQ QRSEMEITDL IKKSYNRAMV KLKLKKSSIN
     DIPDSLQQAA GKLSFDELRQ DLRGKGHSDA EIEAIFAKYD LDGDQELTEH EHQQMRDDLE
     KEREDLDLEH SSLPRPASGR SFSRSQDDSE EDDDEDSGHS SRRRGSSSGG VSYEEFQVLV
     RRVDRMEHSI GSIVSKIDAV IVKLEAMERA KMKRRDVLGR ILDGVMEDER MGRDPELQRE
     QMDRLVRDEL ERWESDDTMS QVSHHHHQAT PIISSAQLRP RSSRPPSSLS NEGPDAAASG
     PAHL
//
